RxSight (RXST) News Today $44.81 -0.31 (-0.69%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Victory Capital Management Inc. Has $12.85 Million Position in RxSight, Inc. (NASDAQ:RXST)Victory Capital Management Inc. increased its stake in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) by 21.0% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 259,864 shares of the compaNovember 21 at 3:17 AM | marketbeat.comRxSight (NASDAQ:RXST) Stock Price Down 1.7% - Time to Sell?RxSight (NASDAQ:RXST) Stock Price Down 1.7% - What's Next?November 20 at 3:17 PM | marketbeat.comRoyce & Associates LP Trims Stock Holdings in RxSight, Inc. (NASDAQ:RXST)Royce & Associates LP lessened its stake in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) by 47.0% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 47,402 shares of the company's stock aNovember 20 at 3:59 AM | marketbeat.comIlya Goldshleger Sells 3,100 Shares of RxSight, Inc. (NASDAQ:RXST) StockNovember 19 at 4:51 AM | insidertrades.comGSA Capital Partners LLP Trims Stock Holdings in RxSight, Inc. (NASDAQ:RXST)GSA Capital Partners LLP reduced its holdings in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) by 41.2% in the third quarter, according to its most recent filing with the SEC. The fund owned 21,084 shares of the company's stock after selling 14,772 shares during the period. GSA Capital PartneNovember 16, 2024 | marketbeat.comLos Angeles Capital Management LLC Invests $988,000 in RxSight, Inc. (NASDAQ:RXST)Los Angeles Capital Management LLC bought a new position in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 19,978 shares of the company's stocNovember 16, 2024 | marketbeat.comRxSight (NASDAQ:RXST) Trading Up 3.4% on Insider Buying ActivityNovember 16, 2024 | americanbankingnews.comInsider Selling: RxSight, Inc. (NASDAQ:RXST) Insider Sells 1,330 Shares of StockNovember 15, 2024 | insidertrades.comRxSight (NASDAQ:RXST) Stock Price Up 3.4% on Insider Buying ActivityRxSight (NASDAQ:RXST) Trading Up 3.4% on Insider Buying ActivityNovember 15, 2024 | marketbeat.comRxSight, Inc. (NASDAQ:RXST) Short Interest UpdateRxSight, Inc. (NASDAQ:RXST - Get Free Report) was the target of a large increase in short interest in the month of October. As of October 31st, there was short interest totalling 2,740,000 shares, an increase of 25.1% from the October 15th total of 2,190,000 shares. Based on an average daily trading volume, of 464,800 shares, the days-to-cover ratio is currently 5.9 days. Approximately 7.2% of the shares of the stock are short sold.November 15, 2024 | marketbeat.comRxSight, Inc. (NASDAQ:RXST) Shares Acquired by Baillie Gifford & Co.Baillie Gifford & Co. increased its stake in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) by 17.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 419,004 shares of the company's stock after acquNovember 13, 2024 | marketbeat.comMorgan Stanley Remains a Buy on RxSight (RXST)November 13, 2024 | markets.businessinsider.comRxSight, Inc. (NASDAQ:RXST) Q3 2024 Earnings Call TranscriptNovember 11, 2024 | msn.comLisanti Capital Growth LLC Reduces Holdings in RxSight, Inc. (NASDAQ:RXST)Lisanti Capital Growth LLC lowered its stake in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) by 26.7% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 69,840 shares of the company's stock after selling 25,380 shNovember 11, 2024 | marketbeat.comRxSight (RXST) Gets a Buy from BTIGNovember 10, 2024 | markets.businessinsider.comRxSight, Inc. (RXST) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | seekingalpha.comRxSight’s Strong Growth and Market Positioning Earns Buy Rating from AnalystNovember 9, 2024 | markets.businessinsider.comRxSight Inc (RXST) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Market ...November 9, 2024 | finance.yahoo.comRxSight (RXST) Receives a Buy from Wells FargoNovember 9, 2024 | markets.businessinsider.comRxSight, Inc. (NASDAQ:RXST) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?November 9, 2024 | finance.yahoo.comRxSight (NASDAQ:RXST) Shares Gap Down - Should You Sell?RxSight (NASDAQ:RXST) Shares Gap Down - Here's WhyNovember 8, 2024 | marketbeat.comRxSight, Inc. Reports Third Quarter 2024 Financial ResultsNovember 7, 2024 | markets.businessinsider.comWhat To Expect From RxSight Inc (RXST) Q3 2024 EarningsNovember 6, 2024 | finance.yahoo.comRxSight, Inc. (NASDAQ:RXST) Given Consensus Recommendation of "Buy" by BrokeragesShares of RxSight, Inc. (NASDAQ:RXST - Get Free Report) have been assigned an average recommendation of "Buy" from the eight research firms that are covering the firm, MarketBeat.com reports. Eight research analysts have rated the stock with a buy rating. The average 12 month target price among brNovember 2, 2024 | marketbeat.comRxSight, Inc. (NASDAQ:RXST) Insider Ilya Goldshleger Sells 3,105 SharesNovember 1, 2024 | insidertrades.comRxSight (RXST) Set to Announce Quarterly Earnings on ThursdayRxSight (NASDAQ:RXST) will be releasing earnings after the market closes on Thursday, November 7, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=640055)October 31, 2024 | marketbeat.comJefferies Initiates Coverage of RxSight (RXST) with Buy RecommendationOctober 30, 2024 | msn.comIlya Goldshleger Sells 3,100 Shares of RxSight, Inc. (NASDAQ:RXST) StockOctober 30, 2024 | insidertrades.comRxSight initiated with a Buy at JefferiesOctober 29, 2024 | msn.comRxSight’s Pioneering Adjustable Lens Technology Poised to Capture Majority Market ShareOctober 29, 2024 | markets.businessinsider.comRxSight (NASDAQ:RXST) Shares Gap Up - Here's What HappenedRxSight (NASDAQ:RXST) Shares Gap Up - Still a Buy?October 29, 2024 | marketbeat.comInsider Selling: RxSight, Inc. (NASDAQ:RXST) Insider Sells 3,100 Shares of StockOctober 29, 2024 | insidertrades.comRxSight, Inc. (NASDAQ:RXST) Shares Sold by Allspring Global Investments Holdings LLCAllspring Global Investments Holdings LLC lowered its stake in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) by 7.0% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 162,730 shares of the company's stock after sellingOctober 27, 2024 | marketbeat.comRxSight, Inc. (NASDAQ:RXST) Insider Sells $154,008.00 in StockOctober 25, 2024 | insidertrades.comRxSight, Inc. to Report Third Quarter Financial Results on November 7, 2024October 24, 2024 | globenewswire.comRxSight, Inc. (NASDAQ:RXST) Insider Ilya Goldshleger Sells 3,100 SharesRxSight, Inc. (NASDAQ:RXST - Get Free Report) insider Ilya Goldshleger sold 3,100 shares of the stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $49.68, for a total value of $154,008.00. Following the sale, the insider now owns 42,246 shares of the company's stock, valued at approximately $2,098,781.28. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.October 22, 2024 | marketbeat.comSG Americas Securities LLC Sells 56,518 Shares of RxSight, Inc. (NASDAQ:RXST)SG Americas Securities LLC lessened its position in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) by 90.6% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,880 shares of the company'sOctober 21, 2024 | marketbeat.comRxSight, Inc. (NASDAQ:RXST) Insider Sells 3,105 SharesOctober 19, 2024 | insidertrades.comRxSight, Inc. (RXST): A Visionary Small-Cap Stock Pick by Hedge FundsOctober 16, 2024 | insidermonkey.comRxSight, Inc. (NASDAQ:RXST) Insider Sells $148,831.00 in StockRxSight, Inc. (NASDAQ:RXST - Get Free Report) insider Ilya Goldshleger sold 3,100 shares of RxSight stock in a transaction that occurred on Friday, October 4th. The stock was sold at an average price of $48.01, for a total transaction of $148,831.00. Following the completion of the sale, the insider now directly owns 42,246 shares in the company, valued at $2,028,230.46. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink.October 8, 2024 | marketbeat.comMillennium Management LLC Cuts Holdings in RxSight, Inc. (NASDAQ:RXST)Millennium Management LLC decreased its position in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) by 46.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 188,586 shares of theOctober 8, 2024 | marketbeat.comRxSight, Inc. (NASDAQ:RXST) Given Average Recommendation of "Buy" by AnalystsShares of RxSight, Inc. (NASDAQ:RXST - Get Free Report) have been assigned a consensus rating of "Buy" from the seven research firms that are covering the firm, MarketBeat reports. Seven research analysts have rated the stock with a buy recommendation. The average 1-year target price among brokeraOctober 8, 2024 | marketbeat.comAQR Capital Management LLC Increases Stock Position in RxSight, Inc. (NASDAQ:RXST)AQR Capital Management LLC raised its stake in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) by 46.8% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 58,634 shares of the company's stock after acquiring an additiOctober 7, 2024 | marketbeat.comHealthcare of Ontario Pension Plan Trust Fund Takes Position in RxSight, Inc. (NASDAQ:RXST)Healthcare of Ontario Pension Plan Trust Fund acquired a new stake in RxSight, Inc. (NASDAQ:RXST - Free Report) during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 61,000 shares of the company's stock, valuOctober 6, 2024 | marketbeat.comPoint72 Asset Management L.P. Has $3.79 Million Stock Position in RxSight, Inc. (NASDAQ:RXST)Point72 Asset Management L.P. grew its position in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) by 279.1% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 62,935 shares of the company's stock after acqOctober 3, 2024 | marketbeat.com41,356 Shares in RxSight, Inc. (NASDAQ:RXST) Acquired by Algert Global LLCAlgert Global LLC acquired a new stake in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) in the 2nd quarter, according to its most recent 13F filing with the SEC. The fund acquired 41,356 shares of the company's stock, valued at approximately $2,488,000. Algert Global LLC owned 0.11% of RxSighOctober 2, 2024 | marketbeat.comRxSight, Inc. (NASDAQ:RXST) Shares Sold by Squarepoint Ops LLCSquarepoint Ops LLC trimmed its stake in RxSight, Inc. (NASDAQ:RXST - Free Report) by 10.5% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 98,040 shares of the company's stock after selling 11,447 shares during the quarter. Squarepoint OpsSeptember 30, 2024 | marketbeat.comDriehaus Capital Management LLC Has $42.49 Million Stock Position in RxSight, Inc. (NASDAQ:RXST)Driehaus Capital Management LLC increased its position in shares of RxSight, Inc. (NASDAQ:RXST - Free Report) by 74.9% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 706,162 shares of the company's stock after acquiSeptember 28, 2024 | marketbeat.comEnsign Peak Advisors Inc Raises Stake in RxSight, Inc. (NASDAQ:RXST)Ensign Peak Advisors Inc increased its stake in RxSight, Inc. (NASDAQ:RXST - Free Report) by 765.6% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 60,568 shares of the company's stock after buying an additional 53,571 shSeptember 27, 2024 | marketbeat.comRxSight (NASDAQ:RXST) Shares Down 3.5% After Insider SellingRxSight (NASDAQ:RXST) Stock Price Down 3.5% After Insider SellingSeptember 24, 2024 | marketbeat.com Get RxSight News Delivered to You Automatically Sign up to receive the latest news and ratings for RXST and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad)Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics… Get Your Free Gold Guide RXST Media Mentions By Week RXST Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RXST News Sentiment▼0.590.46▲Average Medical News Sentiment RXST News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RXST Articles This Week▼134▲RXST Articles Average Week Get RxSight News Delivered to You Automatically Sign up to receive the latest news and ratings for RXST and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Bausch Health Companies News ClearPoint Neuro News Edap Tms News Apyx Medical News Neuronetics News Bausch + Lomb News Inspire Medical Systems News PROCEPT BioRobotics News Axonics News Envista News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RXST) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RxSight, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RxSight With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
